A detailed history of General Partner, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, General Partner, Inc. holds 2,080 shares of NVO stock, worth $129,126. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,080
Previous 880 136.36%
Holding current value
$129,126
Previous $75.7 Million 90.8%
% of portfolio
0.09%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 04, 2025

BUY
$69.3 - $90.95 $83,160 - $109,140
1,200 Added 136.36%
2,080 $144 Million
Q1 2024

Apr 01, 2024

BUY
$102.11 - $135.92 $89,856 - $119,609
880 New
880 $113 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $140B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track General Partner, Inc. Portfolio

Follow General Partner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Partner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on General Partner, Inc. with notifications on news.